The association between hepatic fat content and liver injury in obese children and adolescents: Effects of ethnicity, insulin resistance, and common gene variants

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1353-1360

  Santoro, Nicola ^a   Feldstein, Ariel E ^b   Enoksson, Erik ^a,c   Pierpont, Bridget ^a   Kursawe, Romy ^a   Kim, Grace ^a   Caprio, Sonia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNICITY; FARNESYL DIPHOSPHATE FARNESYL TRANSFERASE 1 GENE; FAT CONTENT; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOKINASE REGULATORY PROTEIN GENE; HISPANIC; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPID STORAGE; LIVER BIOPSY; LIVER INJURY; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATALIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3 GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STEATOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; CHILD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; KERATIN-18; LIPASE; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876814186     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1791     Document Type: Article

References (39)

1. Mencin AA, Lavine JE. Advances in pedi-atric nonalcoholic fatty liver disease. Pediatr Clin North Am 2011;58:1375-1392, x
2. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393 (Pubitemid 46393782)
3. Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic stea-tosis in obese adolescents: is there a link? Hepatology 2009;49:1896-1903
4. Cali AM, Zern TL, Taksali SE, et al. In-trahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: A perfect proatherogenic state. Diabetes Care 2007;30:3093-3098 (Pubitemid 350255255)
5. D'Adamo E, Cali AM, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010;33:1817-1822
6. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40: 1387-1395 (Pubitemid 39657013)
7. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: An insulin resistance paradox? Hepatology 2009;49:791-801
8. Kallwitz ER, Guzman G, TenCate V, et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 2009;104:64-69
9. Bertolani C, Marra F. The role of adipo-kines in liver fibrosis. Pathophysiology 2008;15:91-101
10. Gastaldelli A, Harrison S, Belfort-Aguiar R, et al. Pioglitazone in the treatment of NASH: the role of adiponectin. Aliment Pharmacol Ther 2010;32:769-775
11. Tamimi TI, Elgouhari HM, Alkhouri N, et al. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol 2011; 54:1224-1229
12. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cyto-keratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepa-titis: A multicenter validation study. Hep-atology 2009;50:1072-1078
13. Diab DL, Yerian L, Schauer P, et al. Cyto-keratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastro-enterol Hepatol 2008;6:1249-1254
14. Lebensztejn DM, Wierzbicka A, Socha P, et al. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Acta Biochim Pol 2011;58:563-566
15. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465
16. Santoro N, Kursawe R, D'Adamo E, et al. A common variant in the patatin-like phos-pholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010;52:1281-1290
17. Santoro N, Zhang CK, Zhao H, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 2012;55:781-789
18. Chalasani N, Guo X, Loomba R, et al; Nonalcoholic Steatohepatitis Clinical Research Network. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 2010;139:1567-1576, 1576, e1-e6
19. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007;128:837-847 (Pubitemid 350133997)
20. Kleiner DE, Brunt EM, Van Natta M, et al; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321 (Pubitemid 40770284)
21. Mohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in nonalcoholic fatty liver disease. J Hepatol 2009;50:797-804
22. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42:320-330
23. Neuschwander-Tetri BA. Hepatic lip-otoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010;52:774-788
24. Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2012;55:1389-1397
25. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351 (Pubitemid 40629054)
26. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91-100 (Pubitemid 38056380)
27. Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005; 166:1655-1669 (Pubitemid 40734389)
28. Rees MG, Wincovitch S, Schultz J, et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 2012;55:114-122
29. Valenti L, Al-Serri A, Daly AK, et al. Ho-mozygosity for the patatin-like phospholi-pase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatol-ogy 2010;51:1209-1217
30. Valenti L, Alisi A, Galmozzi E, et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatol-ogy 2010;52:1274-1280
31. Kumari M, Schoiswohl G, Chitraju C, et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyl-transferase. Cell Metab 2012;15:691-702
32. Li JZ, Huang Y, Karaman R, et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest (in press)
33. Ness GC, Zhao Z, Keller RK. Effect of squalene synthase inhibition on the expression of hepatic cholesterol bio-synthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase. Arch Biochem Biophys 1994;311:277-285
34. Schechter I, Conrad DG, Hart I, et al. Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1. Genomics 1994;20:116-118 (Pubitemid 24100928)
35. Okazaki H, Tazoe F, Okazaki S, et al. Increased cholesterol biosynthesis and hypercholesterolemia in mice overex-pressing squalene synthase in the liver. J Lipid Res 2006;47:1950-1958 (Pubitemid 44401982)
36. Farrell GC, van Rooyen DM. Liver cholesterol: is it playing possum in NASH? Am J Physiol Gastrointest Liver Physiol 2012;303:G9-G11
37. Kantartzis K, Peter A, Machicao F, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009;58:2616-2623
38. Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes 2011;60:2011-2017
39. Younossi ZM, Page S, Rafiq N, et al. A biomarker panel for non-alcoholic steato-hepatitis (NASH) and NASH-related fi-brosis. Obes Surg 2011;21:431-439